Concentrations of vascular endothelial growth factor C and D in amniotic fluid and maternal plasma

Acta Obstetricia et Gynecologica Scandinavica

Volumn 88, Issue 6, 2009, Pages 629-634

  Wathén, Katja Anneli ^a   Stenman, Ulf Håkan ^a   Leinonen, Elina ^a   Andersson, Sture ^b   Vuorela, Piia ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Amniotic fluid; Pregnancy; Vascular endothelial growth factor; VEGF C; VEGF D

Indexed keywords

VASCULOTROPIN C; VASCULOTROPIN D; VEGFC PROTEIN, HUMAN;

ADULT; AMNION FLUID ANALYSIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO DEVELOPMENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS DEVELOPMENT; FINLAND; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; HUMAN EXPERIMENT; MATERNAL PLASMA; NORMAL HUMAN; PLACENTA DEVELOPMENT; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; VASCULARIZATION; AMNION FLUID; BLOOD; CHEMISTRY; PREGNANCY;

AMNIOTIC FLUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; PREGNANCY; PREGNANCY TRIMESTERS; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 66149100477     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340902846098     Document Type: Article

References (33)

1. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999;13:9-22.
2. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science. 1989;246:1309-12.
3. Tammela T, Enholm B, Alitalo K, Paavonen K. The biology of vascular endothelial growth factors. Cardiovasc Res. 2005; 65:550-63.
4. Kendall RL, Wang G, Thomas KA. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem Biophys Res Commun. 1996;226:324-8.
5. Ebos JM, Bocci G, Man S, Thorpe PE, Hicklin DJ, Zhou D, et al. A naturally occurring soluble form of vascular endothelial growth factor receptor 2 detected in mouse and human plasma. Mol Cancer Res. 2004;2:315-26.
6. Enholm B, Jussila L, Karkkainen M, Alitalo K. Vascular endothelial growth factor-C: a growth factor for lymphatic and blood vascular endothelial cells. Trends Cardiovasc Med. 1998;8:292-7.
7. Partanen TA, Paavonen K. Lymphatic versus blood vascular endothelial growth factors and receptors in humans. Microsc Res Tech. 2001;55:108-21.
8. Gu B, Alexander JS, Gu Y, Zhang Y, Lewis DF, Wang Y Expression of lymphatic vascular endothelial hyaluronan receptor-1 (LYVE-1) in the human placenta. Lymphat Res Biol. 2006;4:11-7.
9. Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol. 2002;160:1405-23.
10. Farnebo F, Piehl F, Lagercrantz J. Restricted expression pattern of vegf-d in the adult and fetal mouse: high expression in the embryonic lung. Biochem Biophys Res Commun. 1999;257:891-4.
11. Yamada Y, Nezu J, Shimane M, Hirata Y Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. Genomics. 1997;42:483-8.
12. Dunk C, Ahmed A. Expression of VEGF-C and activation of its receptors VEGFR-2 and VEGFR-3 in trophoblast. Histol Histopathol. 2001;16:359-75.
13. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, et al. Failure of blood-island formation and vasculogenesis in flk-1-deficient mice. Nature. 1995;376: 62-6.
14. Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VW, Fang GH, Dumont D, et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA. 1995;92:3566-70.
15. Dumont DJ, Jussila L, Taipale J, Lymboussaki A, Mustonen T, Pajusola K, et al. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science. 1998;282:946-9.
16. Jussila L, Alitalo K. Vascular growth factors and lymphangio-genesis. Physiol Rev. 2002;82:673-700.
17. Clark DE, Smith SK, He Y, Day KA, Licence DR, Corps AN, et al. A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol Reprod. 1998;59:1540-8.
18. Kendal RL, Thomas KA. Inhibition of vascular endothelial growth factor activity by an exogenously encoded soluble receptor. Proc Natl Acad Sci USA. 1993;90:10705-09.
19. Molskness TA, Stouffer RL, Burry KA, Gorrill MJ, Lee DM, Patton PE. Circulating levels of free and total vascular endothelial growth factor (VEGF)-A, soluble VEGF receptors-1 and -2, and angiogenin during ovarian stimulation in non-human primates and women. Hum Reprod. 2004;19: 822-30.
20. Makrydimas G, Sotiriadis A, Savvidou MD, Spencer K, Nicolaides KH. Physiological distribution of placental growth factor and soluble flt-1 in early pregnancy. Prenat Diagn. 2008;28:175-9.
21. Mutter WP, Karumanchi SA. Molecular mechanisms of preeclampsia. Microvasc Res. 2008;75:1-8.
22. Wathen KA, Tuutti E, Stenman UH, Alfthan H, Halmesmaki E, Finne P, et al. Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation. J Clin Endocrinol Metab. 2006;91:180-4.
23. De Vivo A, Baviera G, Giordano D, Todarello G, Corrado F, D'anna R. Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia. Acta Obstet Gynecol Scand. 2008;87:837-42.
24. Vuorela P, Helske S, Hornig C, Alitalo K, Weich H, Halmesmaki E. Amniotic fluid - soluble vascular endothelial growth factor receptor-1 in preeclampsia. Obstet Gynecol. 2000;95:353-7.
25. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003; 111:649-58.
26. Pihkala J, Hakala T, Voutilainen P, Raivio K. Uudet suoma-laiset sikiön kasvukäyrät. [New Finnish fetal growth curves.] (In Finnish. No abstract available). Duodecim. 1989;105: 1541-6.
27. Cheung CY Vascular endothelial growth factor activation of intramembranous absorption: a critical pathway for amniotic fluid volume regulation. J Soc Gynecol Investig. 2004;11: 63-74.
28. Vuorela-Vepsalainen P, Alfthan H, Orpana A, Alitalo K, Stenman UH, Halmesmaki E. Vascular endothelial growth factor is bound in amniotic fluid and maternal serum. Hum Reprod. 1999;14:1346-51.
29. Brace RA. Progress toward understanding the regulation of amniotic fluid volume: water and solute fluxes in and through the fetal membranes. Placenta. 1995;16:1-18.
30. Wolf RB, Moore TR. Amniotic fluid and nonimmune hydrops fetalis. In: Fanaroff AA, Martin RJ, editors. Neonatal-perinatal medicine, diseases of the fetus and infant, 7th edn. St. Louis, MP: Mosby; 2002. p. 351-67.
31. Lash GE, Schiessl B, Kirkley M, Innes BA, Cooper A, Searle RF, et al. Expression of angiogenic growth factors by uterine natural killer cells during early pregnancy. J Leukoc Biol. 2006;80:572-80.
32. Cross JC, Hemberger M, Lu Y, Nozaki T, Whiteley K, Masutani M, et al. Trophoblast functions, angiogenesis and remodeling of the maternal vasculature in the placenta. Mol Cell Endocrinol. 2002;187:207-12.
33. Joory KD, Levick JR, Mortimer PS, Bates DO. Vascular endothelial growth factor-C (VEGF-C) expression in normal human tissues. Lymphat Res Biol. 2006;4:73-82.